Furthermore, as the expression of complement C3 and C3aR1 in the human AD brain are correlated with cognitive decline, the inactivation of C3aR attenuates tau pathology, neuroinflammation, and neurodegeneration in mice models of AD [30]. Here, MAPT is linked to Alzheimer disease.